Ciphergen Shrinks Q2 Loss to $6.8M, Warns Again It Needs Cash to Stay in Business | GenomeWeb
Facing an uncertain future, Ciphergen this week said it shaved its second-quarter loss 11.8 percent to $6.8 million from $7.7 million a year ago despite having no revenues. A year ago, the company posted $5.3 million in receipts.
Overall, the picture for the company remained nearly identical to the prior two quarters as Ciphergen continues its transformation into a diagnostics firm and struggles to stay afloat without any revenue source.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.